Web Based Renal Transplant Patient Medication Education

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2006 by Agency for Healthcare Research and Quality (AHRQ).
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier:
NCT00327483
First received: May 16, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted

May 16, 2006
May 16, 2006
July 2005
Not Provided
Medication errors
Same as current
No Changes Posted
  • Serum creatinine
  • Rejection episodes
  • Rehospitalizations
  • Graft loss
Same as current
Not Provided
Not Provided
 
Web Based Renal Transplant Patient Medication Education
Web Based Renal Transplant Patient Medication Education

Information technology will be brought directly to renal transplant recipients to help them learn about the large number of medications they are required to take on a life long basis, in order to prevent errors and improve safety.

Transplant recipients are particularly vulnerable to medication errors because of the large number of chronic drugs needed to prevent rejection and treat comorbidities. Compliance failures directly compromise patient safety through acute immunologic events and premature graft loss. For society, the loss of invested fiscal and organic (organs) resources is catastrophic. As the unique constant in the chain of people who provide, modify and consume prescription medications, health information technology should be focused on empowering the patient to prevent medication errors. Our principal clinical hypothesis is that HIT can be proven to improve patient safety by minimizing medication errors. Specific aims address the creation of new knowledge and evidence ( in a renal transplant population) of benefits of widely applicable HIT tools. Web enabled education of two groups, new (<6 months) and established (> 6 months), kidney transplant recipients is proposed.

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Renal Transplant Recipients
Behavioral: Internet based education software
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
250
April 2006
Not Provided

Inclusion Criteria:age > 18 or capable of managing own medications

-

Exclusion Criteria:Education level below 10th grade

-

Both
14 Years and older
No
Not Provided
United States
 
NCT00327483
RO1-HS15038-03
Not Provided
Not Provided
Agency for Healthcare Research and Quality (AHRQ)
Not Provided
Principal Investigator: Amy L Friedman, MD Yale University
Agency for Healthcare Research and Quality (AHRQ)
May 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP